Loading…
Loading…
Largest ALTAIR io 6 contract to date underscores growing demand for connected worker safety technology PITTSBURGH, Oct. 22, 2026 /PRNewswire/ -- MSA Safety Inc., (NYSE: MSA), a global leader in advanced safety technology, today announced it is proud to partner with one of the largest utility providers in the northeast United States as the utility invests in connected technologies that support worker safety to better serve their communities. The major U.S. energy utility selected the MSA Safety ALTAIR io™ 6 Multigas Detector to help enhance worker safety and operational efficiency.
PITTSBURGH, Oct. 20, 2026 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, today announced that it will host the company's third quarter 2026 earnings conference call on Tuesday, November 3, 2026, at 10:00 a.m. Eastern Time.
MSA Safety (MSA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MSA Safety (MSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Broadwind Energy (NASDAQ: BWEN - Get Free Report) and MSA Safety Incorporporated (NYSE: MSA - Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Analyst Ratings This is a breakdown of
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDSÂ 2026PR NewswireVALBY,
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has asked the US Food and Drug Administration to grant orphan drug designation to its intranasal foralumab for multiple system atrophy (MSA), a rare neurodegenerative disease with no approved disease-modifying therapies. MSA is a rapidly progressive disorder that affects autonomic functions such as blood pressure and bladder control, as well as motor control, leading to severe disability and shortened life expectancy.
Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain. Despite aggregate weakness, 29 Dividend Kings appear both undervalued and offer a long-term expected return of at least 10%. Recent dividend increases and higher projected earnings growth have modestly improved the Kings' average dividend growth rate to 4.49%.